Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Renal Transplant Candidate for Left Kidney: later-stage trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Renal Transplant Candidate for Left Kidney: 1 US clinical trial tracked, none currently recruiting.

Renal Transplant Candidate for Left Kidney is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Rutgers, The State University of New Jersey, running 1 of these trials.

Enrollment posture brief

Registry condition renal-transplant-candidate-for-left-kidney

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Renal Transplant Candida (th…0%
Open-enrollment share among volume-matched conditions near Renal Transplant Candidate for Left Kidney

Renal Transplant Candidate for Left Kidney has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Renal Transplant Candidate for Left Kidney on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Renal Transplant Candidate for Left Kidney is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Renal Transplant Candidate for Left Kidney records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

1 month Rifapentine, Isoniazid and Vitamin B6 Drug
1 trials

US sites by state

Facility locations filed on Renal Transplant Candidate for Left Kidney trials. A trial with sites in several states counts in each.

New Jersey 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Renal Transplant Candidate for Left Kidney page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Renal Transplant Candidate for Left Kidney trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Rutgers, The State University of New Jersey sponsors the most Renal Transplant Candidate for Left Kidney trials on record, review their full trial history before evaluating a specific study. See Rutgers, The State University of New Jersey's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Renal Transplant Candidate for Left Kidney condition card totals 1 registered trials; most-linked intervention 1 month Rifapentine, Isoniazid and Vitamin B6; top US site state New Jersey. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.